Fig. 3From: Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapyKaplan Meier curves of MammaTyper® MKI67 positive (high) vs. MKI67 negative (low) in ESR1+/ERBB2- tumors: MKI67 negative cases were statistically significantly associated with better distant disease-free survivalBack to article page